1. A Pilot Study.

    Related Articles INTRAVITREAL BEVACIZUMAB (AVASTIN) AS A TREATMENT FOR REFRACTORY MACULAR EDEMA IN PATIENTS WITH UVEITIS: A Pilot Study. Retina. 2008 Jan;28(1):41-45 Authors: Mackensen F, Heinz C, Becker MD, Heiligenhaus A PURPOSE:: Bevacizumab is a monoclonal antibody to vascular endothelial growth factor (VEGF) which has been successfully used for the treatment of age-related macular degeneration with choroidal neovascularization. As VEGF is involved in the pathomechanisms of inflammation and endothelial dysfunction the authors used bevacizumab as a last resort treatment in patients with persistent uveitic cystoid macular edema (CME). PATIENTS AND METHODS:: Persistent uveitic CME was defined by ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned

  3. Authors